Development of phage resistance in clinical Escherichia coli and Klebsiella pneumoniae isolates
Tekijät
Päivämäärä
2024Pääsyrajoitukset
Tekijä ei ole antanut lupaa avoimeen julkaisuun, joten aineisto on luettavissa vain Jyväskylän yliopiston kirjaston arkistotyösemalta. Ks. https://kirjasto.jyu.fi/fi/tyoskentelytilat/laitteet-ja-tilat#autotoc-item-autotoc-2.
Tekijänoikeudet
© The Author(s)
Antimicrobial resistance (AMR) is an escalating global health threat, attributable to the diminishing availability of efficient antibiotics against bacterial infections. Phage therapy is considered an alternative therapeutic solution to treat resistant infections. In phage therapy, the bacteria are treated with phages, which are natural viruses that infect bacteria. However, the development of phage resistance in bacterial communities can be affected by various host-associated factors. Mucin is a glycoprotein found in the mucosal layer of the human gut, which primarily protects the cellular surface. The interactions between bacteria and phages often occur in the mucous membrane. Also, recent studies have found the potential of mucin to alter phage-bacteria interactions. In this research, the evolution of phage resistance in Escherichia coli and Klebsiella pneumoniae strains was studied in the presence of mucin and antibiotics. First, bacterial growth was measured under various mucin and antibiotic concentrations in the absence of phage to select optimal conditions for the evolution experiment. In the evolution experiment, ESBL-producing E. coli and K. pneumoniae strains were sequentially exposed to phages, one at a time, in the presence of tetracycline and/or mucin. After the experiment, the development of phage resistance was tested in the exposed bacteria by a co-culture experiment. The results demonstrate that the phage-treated bacteria exhibited consistent development of phage resistance compared to the original strains. In an effort to develop efficient phage therapy, the findings of this research help comprehend the potential factors that may hamper the successful treatment of bacterial infections.
...
Asiasanat
Metadata
Näytä kaikki kuvailutiedotKokoelmat
- Pro gradu -tutkielmat [28254]
Lisenssi
Samankaltainen aineisto
Näytetään aineistoja, joilla on samankaltainen nimeke tai asiasanat.
-
Effects of Combined Use of Bacteriophages and Antibiotics to Eliminate Escherichia coli in Bacterial Biofilm
Valkonen, Sofia (2022)Antibiootit ovat yksi modernin historian menestyksekkäimmistä lääketieteellisistä löydöistä, ja niillä on ollut tärkeä rooli patogeenisten bakteerien aiheuttamien infektioiden torjunnassa. Vuosikymmeniä kestänyt antibioottien ... -
Klebsiella pneumoniae -bakteerilajia infektoivien faagien eristys ja faagiresistenssimekanismien kartoittaminen
Thind, Navjot (2021)Antibioottivastustuskykyisten Klebsiella pneumoniae -bakteerikantojen aiheuttamat infektiot ovat globaalisti kasvava ongelma, sillä ne saattavat olla resistenttejä kaikille kliinisessä käytössä oleville antibiooteille. ... -
Beta-Lactam Sensitive Bacteria Can Acquire ESBL-Resistance via Conjugation after Long-Term Exposure to Lethal Antibiotic Concentration
Ruotsalainen, Pilvi; Given, Cindy; Penttinen, Reetta; Jalasvuori, Matti (MDPI, 2020)Beta-lactams are commonly used antibiotics that prevent cell-wall biosynthesis. Beta-lactam sensitive bacteria can acquire conjugative resistance elements and hence become resistant even after being exposed to lethal (above ... -
Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains
Koskinen, Katariina; Penttinen, Reetta; Örmälä-Odegrip, Anni-Maria; Giske, Christian G.; Ketola, Tarmo; Jalasvuori, Matti (Frontiers Media, 2021)Over the past few decades, extensively drug resistant (XDR) resistant Klebsiella pneumoniae has become a notable burden to healthcare all over the world. Especially carbapenemase-producing strains are problematic due to ... -
Potential of phage therapy against uropathogenic antibiotic resistant Escherichia coli biofilms
Telimaa, Heta (2023)Urinary tract infections (UTIs) are one of the most common bacterial infections in the world. The majority of UTIs are caused by uropathogenic E. coli (UPEC) which tend to live in surface-attached microbe communities, known ...
Ellei toisin mainittu, julkisesti saatavilla olevia JYX-metatietoja (poislukien tiivistelmät) saa vapaasti uudelleenkäyttää CC0-lisenssillä.